1048 GMT - Praram 9 Hospital's earnings could be supported by stronger patient inflows from the Middle East, say DBS Group Research's Sasikarn Udomvej in a note, adding the improvement is likely to be significant in 2Q. The Thai hospital operator expects revenue contribution from this segment to exceed prior levels, the analyst says, adding revenue from Qatar could notch a new high on strong demand for heart and neurology services. The analyst stays cautious about the company's revenue growth guidance of low-to-mid single-digit, citing uncertainty around the U.S.-Iran war. DBS lowers its target price to 22.00 baht from 23.00 baht while retaining a buy rating on the stock, which closed 0.6% higher at THB16.00. (megan.cheah@wsj.com)
(END) Dow Jones Newswires
May 19, 2026 06:48 ET (10:48 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.